Related Experiment Video
Updated: May 31, 2025

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Trifolirhizin: A Phytochemical with Multiple Pharmacological Properties
Varun Jaiswal1, Hae-Jeung Lee1,2,3,4
1Department of Food and Nutrition, College of BioNano Technology, Gachon University, 1342 Seongnam-daero, Sujeong-gu, Seongnam-si 13120, Republic of Korea.
Trifolirhizin, a flavonoid glycoside from medicinal plants, exhibits diverse pharmacological effects including anti-inflammatory and anticancer properties. This review compiles its activities and molecular targets, highlighting its therapeutic potential.
Area of Science:
- Phytochemistry
- Pharmacology
- Molecular Biology
Background:
- Trifolirhizin is a key flavonoid glycoside found in several medicinal plants.
- It is recognized for contributing to the therapeutic benefits of these plants.
- Its pharmacological profile includes anti-inflammatory, antioxidant, and anticancer activities.
Purpose of the Study:
- To comprehensively review the pharmacological properties of trifolirhizin.
- To elucidate the molecular mechanisms and target pathways of trifolirhizin.
- To identify research gaps and propose future directions for trifolirhizin's therapeutic development.
Main Methods:
- Literature review of scientific databases.
- Compilation and analysis of published studies on trifolirhizin's pharmacology.
- Synthesis of data on its molecular targets and signaling pathways.
Main Results:
- Trifolirhizin demonstrates a broad spectrum of activities: anti-inflammatory, antioxidant, antibacterial, anti-ulcerative colitis, antiasthma, hepatoprotective, osteogenic, skin-whitening, wound-healing, and anticancer.
- Key signaling pathways modulated by trifolirhizin include NF-κB-MAPK, EGFR-MAPK, AMPK/mTOR, and PI3K/Akt.
- Pharmacokinetic data suggest its potential for therapeutic applications.
Conclusions:
- Trifolirhizin possesses significant therapeutic potential due to its diverse pharmacological activities and ability to modulate critical signaling pathways.
- This review consolidates existing knowledge, addressing gaps in understanding its mechanisms and applications.
- Further research is warranted to fully explore and develop trifolirhizin for clinical use.
More Related Videos
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Cholinergic Antagonists: Pharmacokinetics
Antihypertensive Drugs: Thiazide-Class Diuretics
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antipsychotic Drugs: Typical and Atypical Agents